Inflammatory status and cartilage regenerative potential of synovial fibroblasts from patients with osteoarthritis and chondropathy.
OBJECTIVE
To evaluate the inflammatory status and the cartilage regenerative potential of pathological synovial fibroblasts from patients with osteoarthritis (OA) compared with non-inflamed synovium (NS)-derived cells from patients with chondropathy.


METHODS
The inflammatory cell phenotype was investigated based on the constitutive and inducible surface expression and secretion of various effector molecules using flow cytometry or ELISA assays. The capacity of cells to produce cartilage-like extracellular matrix was assessed using acid Alcian blue staining and type II collagen immunostaining after treatment with transforming growth factor beta1 (TGF-beta1).


RESULTS
OA and NS fibroblasts consistently expressed CD29, CD44, CD49e, CD54, CD90 and CD106. Expression of high-affinity receptors for IL-4, IL-15, CXCL8 and CXCL12 was also detected but only intracellularly. All types of fibroblasts spontaneously released abundant amounts of CXCL12, CCL2, IL-6 and tissue inhibitor of metalloproteinase 1, while the production of IL-11, TGF-beta1, matrix metalloproteinase 1 (MMP-1) and MMP-9 was detected at moderate levels. Several other secreted factors remained undetectable. No statistically significant differences were noted between the two groups of fibroblasts. Treatment with the proinflammatory cytokine tumour necrosis factor alpha (TNF-alpha) up-regulated the same set of surface and secreted molecules, including CD54, CD106, membrane IL-15, CCL2 and CCL5. Under TGF-beta1 treatment and adipogenic culture conditions, both OA and NS fibroblasts displayed chondrogenic and adipocytic activities that were reduced in OA compared with NS cells.


CONCLUSIONS
OA synovial fibroblasts did not display a distinct activated inflammatory phenotype compared with NS cells. However, they did differ in their reduced ability to produce cartilage-like matrix. This difference may be an additional important factor contributing to OA pathogenesis.
Fiorito
S
S
Laboratoire d'Immunologie, Université Montpellier-1, Polyclinique St Roch, France.
Magrini
L
L
Adrey
J
J
Mailhé
D
D
Brouty-Boyé
D
D
D017667:Adipocytes / Q000378:metabolism; D000368:Aged; D015703:Antigens, CD / Q000032:analysis; D002358:Cartilage, Articular / Q000254:growth & development* / Q000473:pathology; D015815:Cell Adhesion Molecules / Q000032:analysis; D002478:Cells, Cultured; D018925:Chemokines / Q000032:analysis; D016207:Cytokines / Q000032:analysis; D005260:Female; D005347:Fibroblasts / Q000473:pathology*; D006801:Humans; D007592:Joint Diseases / Q000473:pathology*; D007719:Knee Joint / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D015207:Osteoarthritis, Hip / Q000473:pathology*; D010641:Phenotype; D013582:Synovial Fluid / Q000166:cytology*
D015703:Antigens, CD; D015815:Cell Adhesion Molecules; D018925:Chemokines; D016207:Cytokines